1. Home
  2. SCPH vs OXSQ Comparison

SCPH vs OXSQ Comparison

Compare SCPH & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • OXSQ
  • Stock Information
  • Founded
  • SCPH 2013
  • OXSQ 2003
  • Country
  • SCPH United States
  • OXSQ United States
  • Employees
  • SCPH N/A
  • OXSQ N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • OXSQ Blank Checks
  • Sector
  • SCPH Health Care
  • OXSQ Finance
  • Exchange
  • SCPH Nasdaq
  • OXSQ Nasdaq
  • Market Cap
  • SCPH 173.6M
  • OXSQ 190.1M
  • IPO Year
  • SCPH 2017
  • OXSQ N/A
  • Fundamental
  • Price
  • SCPH $2.78
  • OXSQ $2.56
  • Analyst Decision
  • SCPH Strong Buy
  • OXSQ
  • Analyst Count
  • SCPH 3
  • OXSQ 0
  • Target Price
  • SCPH $14.00
  • OXSQ N/A
  • AVG Volume (30 Days)
  • SCPH 629.3K
  • OXSQ 457.1K
  • Earning Date
  • SCPH 03-19-2025
  • OXSQ 05-01-2025
  • Dividend Yield
  • SCPH N/A
  • OXSQ 16.44%
  • EPS Growth
  • SCPH N/A
  • OXSQ N/A
  • EPS
  • SCPH N/A
  • OXSQ 0.09
  • Revenue
  • SCPH $36,332,000.00
  • OXSQ $42,683,205.00
  • Revenue This Year
  • SCPH $134.20
  • OXSQ $8.73
  • Revenue Next Year
  • SCPH $99.40
  • OXSQ N/A
  • P/E Ratio
  • SCPH N/A
  • OXSQ $27.74
  • Revenue Growth
  • SCPH 167.28
  • OXSQ N/A
  • 52 Week Low
  • SCPH $2.72
  • OXSQ $2.40
  • 52 Week High
  • SCPH $5.65
  • OXSQ $3.29
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 34.45
  • OXSQ 29.64
  • Support Level
  • SCPH $2.87
  • OXSQ $2.56
  • Resistance Level
  • SCPH $3.08
  • OXSQ $2.61
  • Average True Range (ATR)
  • SCPH 0.18
  • OXSQ 0.05
  • MACD
  • SCPH -0.00
  • OXSQ -0.01
  • Stochastic Oscillator
  • SCPH 11.70
  • OXSQ 8.00

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About OXSQ Oxford Square Capital Corp.

Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing, and Diversified Insurance.

Share on Social Networks: